Evidence of adrenergic--cholinergic interaction in the central nervous system. II. Dopamine and its analogues.
D000217:Acyltransferases / Q000032:analysis; D000818:Animals; D001921:Brain / Q000201:enzymology; D001923:Brain Chemistry / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects*; D002794:Choline; D004298:Dopamine / Q000032:analysis / Q000494:pharmacology*; D006892:Hydroxydopamines / Q000494:pharmacology*; D008297:Male; D009638:Norepinephrine / Q000032:analysis; D010277:Parasympathomimetics / Q000494:pharmacology*; D051381:Rats; D011941:Receptors, Adrenergic; D011950:Receptors, Cholinergic; D012701:Serotonin / Q000032:analysis; D013566:Sympathomimetics / Q000494:pharmacology*; D009435:Synaptic Transmission
D006892:Hydroxydopamines; D010277:Parasympathomimetics; D011941:Receptors, Adrenergic; D011950:Receptors, Cholinergic; D013566:Sympathomimetics; D012701:Serotonin; D000217:Acyltransferases; D002794:Choline; D004298:Dopamine; D009638:Norepinephrine